Mpox is a rare viral infection, with a recent increase in cases throughout many parts of the world, including Canada. The virus spreads through close, physical contact, particularly through contact with an infected person 91ÖÆÆ¬³§ ’s rash or bodily fluids such as blood, saliva, and semen. The virus may also spread through respiratory particles (e.g. from talking, breathing, coughing, sneezing) during prolonged close contact.
Symptoms include:
- Rash (sometimes painful) on mouth, genitals, face, arm and legs, and feet and hands
- Fever
- Chills
- Swollen glands
- Headache
- Muscle and joint pain
- Exhaustion
People usually develop symptoms 5 to 21 days after exposure are contagious from the onset of symptoms until skin has healed.
If students experience symptoms, they should stay away from others and contact a healthcare provider immediately for advice on testing and medical care. This viral infection typically goes away on its own within 2-4 weeks but, in some cases, it can be severe and potentially life-threatening.
Mpox Vaccine
People who are eligible can get a two-dose vaccine which can be used to protect against Mpox (i.e., (Pre-Exposure Prophylaxis – PrEP) or after exposure (i.e., Post-Exposure Prophylaxis – PEP).
For more information about Mpox including who is eligible for the vaccine, see the and/or the websites.